These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31992093)

  • 1. C-2 phenyl replacements to obtain potent quinoline-based
    Felicetti T; Mangiaterra G; Cannalire R; Cedraro N; Pietrella D; Astolfi A; Massari S; Tabarrini O; Manfroni G; Barreca ML; Cecchetti V; Biavasco F; Sabatini S
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):584-597. PubMed ID: 31992093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New
    Cannalire R; Mangiaterra G; Felicetti T; Astolfi A; Cedraro N; Massari S; Manfroni G; Tabarrini O; Vaiasicca S; Barreca ML; Cecchetti V; Biavasco F; Sabatini S
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position.
    Felicetti T; Cannalire R; Nizi MG; Tabarrini O; Massari S; Barreca ML; Manfroni G; Schindler BD; Cecchetti V; Kaatz GW; Sabatini S
    Eur J Med Chem; 2018 Jul; 155():428-433. PubMed ID: 29908437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues.
    Felicetti T; Cannalire R; Burali MS; Massari S; Manfroni G; Barreca ML; Tabarrini O; Schindler BD; Sabatini S; Kaatz GW; Cecchetti V
    ChemMedChem; 2017 Aug; 12(16):1293-1302. PubMed ID: 28598572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
    Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
    J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
    Sabatini S; Gosetto F; Manfroni G; Tabarrini O; Kaatz GW; Patel D; Cecchetti V
    J Med Chem; 2011 Aug; 54(16):5722-36. PubMed ID: 21751791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
    Rath SK; Singh S; Kumar S; Wani NA; Rai R; Koul S; Khan IA; Sangwan PL
    Bioorg Med Chem; 2019 Jan; 27(2):343-353. PubMed ID: 30552006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search.
    Cedraro N; Cannalire R; Astolfi A; Mangiaterra G; Felicetti T; Vaiasicca S; Cernicchi G; Massari S; Manfroni G; Tabarrini O; Cecchetti V; Barreca ML; Biavasco F; Sabatini S
    ChemMedChem; 2021 Oct; 16(19):3044-3059. PubMed ID: 34032014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
    J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
    Felicetti T; Cannalire R; Pietrella D; Latacz G; Lubelska A; Manfroni G; Barreca ML; Massari S; Tabarrini O; Kieć-Kononowicz K; Schindler BD; Kaatz GW; Cecchetti V; Sabatini S
    J Med Chem; 2018 Sep; 61(17):7827-7848. PubMed ID: 30067360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
    Naaz F; Khan A; Kumari A; Ali I; Ahmad F; Ahmad Lone B; Ahmad N; Ali Khan I; Rajput VS; Grover A; Shafi S
    Bioorg Chem; 2021 Aug; 113():105031. PubMed ID: 34089943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus.
    Wani NA; Singh S; Farooq S; Shankar S; Koul S; Khan IA; Rai R
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4174-8. PubMed ID: 27503686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors.
    Kumar G; Goutami Godavari A; Tambat R; Kumar S; Nandanwar H; Elizabeth Sobhia M; Jachak SM
    Bioorg Chem; 2020 Nov; 104():104225. PubMed ID: 32992278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the NorA efflux pump of S. aureus by (Z)-5-(4-Fluorobenzylidene)-Imidazolidines.
    Faillace MS; Alves Borges Leal AL; Araújo de Oliveira Alcântara F; Ferreira JHL; de Siqueira-Júnior JP; Sampaio Nogueira CE; Barreto HM; Peláez WJ
    Bioorg Med Chem Lett; 2021 Jan; 31():127670. PubMed ID: 33161124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinedione and thiazole derivatives potentiate norfloxacin activity against NorA efflux pump over expression in Staphylococcus aureus 1199B strains.
    Pereira PS; Lima MDCA; Neto PPM; Oliveira-Tintino CDM; Tintino SR; Menezes IRA; de Oliveira JF; Marchand P; Coutinho HDM; Rodrigues MDD; da Silva TG
    Bioorg Med Chem; 2019 Sep; 27(17):3797-3804. PubMed ID: 31320212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
    Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
    Deka B; Suri M; Sarma S; Devi MV; Bora A; Sen T; Dihingia A; Pahari P; Singh AK
    Bioorg Med Chem; 2022 Jan; 54():116580. PubMed ID: 34953341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains.
    Felicetti T; Cedraro N; Astolfi A; Cernicchi G; Mangiaterra G; Vaiasicca S; Massari S; Manfroni G; Barreca ML; Tabarrini O; Biavasco F; Cecchetti V; Vignaroli C; Sabatini S
    Eur J Med Chem; 2022 Nov; 241():114656. PubMed ID: 35963131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump.
    Dantas N; de Aquino TM; de Araújo-Júnior JX; da Silva-Júnior E; Gomes EA; Gomes AAS; Siqueira-Júnior JP; Mendonça Junior FJB
    Chem Biol Interact; 2018 Jan; 280():8-14. PubMed ID: 29208359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
    Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
    J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.